Evidence map›Paper›PMID 32677087›Full record

ArticleThe EMBO journal2020

A small targeting domain in Ty1 integrase is sufficient to direct retrotransposon integration upstream of tRNA genes.

Amna Asif-Laidin, Christine Conesa, Amandine Bonnet, Camille Grison, Indranil Adhya, Rachid Menouni, Hélène Fayol, Noé Palmic, Joël Acker, Pascale Lesage

Abstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. An interchangeable prion-like domain is required for Ty1 retrotransposition.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amna Asif-LaidinINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.ORCID 0000-0001-7563-4196
Christine Conesa *CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, Gif-sur-Yvette, France.
Amandine Bonnet *INSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.ORCID 0000-0002-3485-8713
Camille GrisonINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.
Indranil AdhyaCEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, Gif-sur-Yvette, France.
Rachid MenouniINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.
Hélène FayolINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.
Noé PalmicINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.ORCID 0000-0001-6545-9005
Joël AckerCEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, Gif-sur-Yvette, France.ORCID 0000-0002-0855-875X
Pascale LesageINSERM U944, CNRS UMR 7212, Genomes& Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Université de Paris, Paris, France.ORCID 0000-0002-4221-8038

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0005-02Agence Nationale de la Recherche ANR11-LABX-0071Agence Nationale de la Recherche ANR-13-BSV3-0012Agence Nationale de la Recherche ANR-17-CE11-0025Centre National de la Recherche Scientifique (CNRS)Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA) (PhD program)Fondation ARC pour la Recherche sur le Cancer PJA 20151203412Fondation pour la Recherche Médicale FRM-SPF20170938755Université Paris Diderot and the Institut National de la Santé et de la Recherche Médicale (INSERM)
6 · The paper itself

Abstract

Integration of transposable elements into the genome is mutagenic. Mechanisms targeting integrations into relatively safe locations, hence minimizing deleterious consequences for cell fitness, have emerged during evolution. In budding yeast, integration of the Ty1 LTR retrotransposon upstream of RNA polymerase III (Pol III)-transcribed genes requires interaction between Ty1 integrase (IN1) and AC40, a subunit common to Pol I and Pol III. Here, we identify the Ty1 targeting domain of IN1 that ensures (i) IN1 binding to Pol I and Pol III through AC40, (ii) IN1 genome-wide recruitment to Pol I- and Pol III-transcribed genes, and (iii) Ty1 integration only at Pol III-transcribed genes, while IN1 recruitment by AC40 is insufficient to target Ty1 integration into Pol I-transcribed genes. Swapping the targeting domains between Ty5 and Ty1 integrases causes Ty5 integration at Pol III-transcribed genes, indicating that the targeting domain of IN1 alone confers Ty1 integration site specificity.

Indexed as

RetroelementsIntegrasesRNA Polymerase IRNA Polymerase IIIRNA, TransferSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsIntegrasesRetroelementsRNA Polymerase IRNA Polymerase IIIRNA, TransferSaccharomyces cerevisiae Proteinsgenome-wide de novo insertion sitesintegrase genome-wide occupancyRNA Polymerases I and IIITy1 retrotransposon

Identifiers

PMID32677087
PMCPMC7459421

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.